
THE KEY TO PRECISION ONCOLOGY
Indivumed Therapeutics is a biotech company focused on precision oncology. We create screening-ready novel target packages and partner with the pharmaceutical industry to develop precision cancer therapeutics.
With our global network of selected partner clinics, we have created unique protocols and procedures to collect tissue of unmatched quality and variety. By systematically characterizing the tissue at a molecular level and linking it with longitudinal clinical data, we can unravel novel targets that would otherwise be undetectable.
Combining biomathematics, bioinformatics, and cell biology, we identify targets and design proof-of-concept drug screening assays for successful development further down the pipeline.

COMPANY HISTORY
Change is part of our history. For over 20 years, Indivumed has continued to evolve, forging valuable relationships around the world, and earning an outstanding reputation in the scientific community. We are always looking for new partnerships and methods to support the realization of our vision.
Explore the highlights of our journey:
INDIVUMED THERAPEUTICS MANAGEMENT TEAM
“We envision a world where precision therapy offers a cure for every cancer patient.”
Prof. Dr. med. Hartmut Juhl, Founder and CEO

Prof. Dr. med. Hartmut Juhl
Founder and Chief Executive Officer

Nils Schumacher
Chief Operating Officer

Dr. Jobst Landgrebe
Head of R&D and Chief Technology Strategist

Dr. Stephan Schüller
Chief Financial Officer

Martin Heuseler
Vice President Finance & Controlling

Nina Gabelia, MD, MPH
Vice President Clinical Network

Daniel Beck
Vice President Biomathematics & Bioinformatics

Dr. Jonathan Woodsmith
Vice President Scientific Alliances

Hans Vanhooren, PhD
Vice President Business Development

Kristin Maack
Vice President Marketing & Corporate Communications

Rene Steen
Vice President Information Technology
INTERESTED? INTRIGUED? INSPIRED?
If you are interested in a collaborative partnership or see Indivumed as your next employer, please do not hesitate to get in touch. We look forward to hearing from you.